Aytu BioPharma Inc [AYTU] stock prices are up 3.81% to $2.18 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The AYTU shares have gain 10.10% over the last week, with a monthly amount glided 19.13%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Aytu BioPharma Inc [NASDAQ: AYTU] stock has seen the most recent analyst activity on June 30, 2025, when Ascendiant Capital Markets initiated its Buy rating and assigned the stock a price target of $12. Previously, Cantor Fitzgerald started tracking the stock with Overweight rating on March 30, 2021, and set its price target to $11. On May 29, 2020, H.C. Wainwright initiated with a Buy rating and assigned a price target of $3 on the stock.
The stock price of Aytu BioPharma Inc [AYTU] has been fluctuating between $0.95 and $2.96 over the past year. Aytu BioPharma Inc [NASDAQ: AYTU] shares were valued at $2.18 at the most recent close of the market.
Analyzing the AYTU fundamentals
The Aytu BioPharma Inc [NASDAQ:AYTU] reported sales of 69.22M for trailing twelve months, representing a surge of 2.55%. Gross Profit Margin for this corporation currently stands at 0.69% with Operating Profit Margin at -0.06%, Pretax Profit Margin comes in at 0.03%, and Net Profit Margin reading is 0.02%. To continue investigating profitability, this company’s Return on Assets is posted at 0.01, Equity is 0.05 and Total Capital is -0.07. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.05.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.05 points at the first support level, and at 1.91 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.36, and for the 2nd resistance point, it is at 2.53.
Ratios To Look Out For
It’s worth pointing out that Aytu BioPharma Inc [NASDAQ:AYTU]’s Current Ratio is 1.03. On the other hand, the Quick Ratio is 0.87, and the Cash Ratio is 0.26. Considering the valuation of this stock, the price to sales ratio is 0.19, the price to book ratio is 0.39.
Transactions by insiders
Recent insider trading involved Disbrow Jarrett, Chief Business Officer, that happened on Jun 09 ’25 when 16666.0 shares were purchased. Chief Executive Officer, Disbrow Joshua R. completed a deal on Jun 09 ’25 to buy 66666.0 shares. Meanwhile, Chief Executive Officer Disbrow Joshua R. bought 15000.0 shares on Feb 28 ’25.
